Special Issues

Pharmacoepidemiology publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process. The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue policies and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.

Search by Title/Keyword
 
Order results
Display
Results per page
The Pharmacoepidemiology of Antipsychotics: Utilization, Safety and Effectiveness in Real-World Settings
edited by Yi Chai
submission deadline 30 Sep 2026 | Viewed by 1038 | Submission Open
Keywords: antipsychotics; psychopharmacology; pharmacoepidemiology; real-world evidence (RWE); electronic health records (EHR)
A Global Perspective on Advancing Drug Development and Labeling for Understudied Populations submission deadline 30 Nov 2026 | Viewed by 651 | Submission Open
Keywords: drug development; international regulation; drug safety; drug efficacy; pharmacoepidemiology
Women’s Special Issue Series: Pharmacoepidemiology
edited by , Li-Chia Chen and
submission deadline 31 Jan 2027 | 3 articles | Viewed by 6694 | Submission Open
Keywords: pharmacoepidemiology; pharmacovigilance; preventative pharmacovigilance; ecopharmacovigilance; patient safety; patterns in drug utilization; polypharmacology; randomized controlled drug trials; post-marketing surveillance; pharmacoeconomics
Bridging Pharmacoepidemiology, Pharmacoeconomics, and Health Technology Assessment in Low- and Middle-Income Countries: Using Real-World Evidence for Sustainable Healthcare Decisions submission deadline 30 Sep 2027 | Viewed by 339 | Submission Open
Keywords: pharmacoepidemiology; pharmacoeconomics; health technology assessment (HTA); real-world evidence (RWE); real-world data (RWD); low- and middle-income countries (LMICs); comparative effectiveness and drug safety; decision-analytic modeling
Back to TopTop